These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 33643578)

  • 1. Rapid releasing naproxen Liqui-Pellet using effervescent agent and neusilin US2.
    Lam M; Asare-Addo K; Nokhodchi A
    Iran J Basic Med Sci; 2021 Jan; 24(1):108-115. PubMed ID: 33643578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors affecting performance and manufacturability of naproxen Liqui-Pellet.
    Lam M; Nokhodchi A
    Daru; 2020 Dec; 28(2):567-579. PubMed ID: 32757155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimising the release rate of naproxen liqui-pellet: a new technology for emerging novel oral dosage form.
    Lam M; Ghafourian T; Nokhodchi A
    Drug Deliv Transl Res; 2020 Feb; 10(1):43-58. PubMed ID: 31286452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liqui-Tablet: the Innovative Oral Dosage Form Using the Newly Developed Liqui-Mass Technology.
    Lam M; Asare-Addo K; Nokhodchi A
    AAPS PharmSciTech; 2021 Mar; 22(3):85. PubMed ID: 33650023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liqui-Mass Technology as a Novel Tool to Produce Sustained Release Liqui-Tablet Made from Liqui-Pellets.
    Lam M; Nashed N; Nokhodchi A
    Pharmaceutics; 2021 Jul; 13(7):. PubMed ID: 34371739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liqui-Pellet: the Emerging Next-Generation Oral Dosage Form Which Stems from Liquisolid Concept in Combination with Pelletization Technology.
    Lam M; Ghafourian T; Nokhodchi A
    AAPS PharmSciTech; 2019 Jun; 20(6):231. PubMed ID: 31236781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In-vitro and in-vivo evaluation of enteric-coated starch-based pellets prepared via extrusion/spheronisation.
    Dukić-Ott A; De Beer T; Remon JP; Baeyens W; Foreman P; Vervaet C
    Eur J Pharm Biopharm; 2008 Sep; 70(1):302-12. PubMed ID: 18579353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liquisolid System and Liqui-Mass System Are Not the Same.
    Lam M; Ghafourian T; Nokhodchi A
    AAPS PharmSciTech; 2020 Mar; 21(3):105. PubMed ID: 32180042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of formulation and excipient variables on the pellet properties prepared by extrusion spheronization.
    Sinha VR; Agrawal MK; Kumria R
    Curr Drug Deliv; 2005 Jan; 2(1):1-8. PubMed ID: 16305403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liquisolid Pellets and Liqui-Pellets Are Not Different.
    Pezzini BR; Beringhs AO; Ferraz HG; Silva MAS; Stulzer HK; Sonaglio D
    AAPS PharmSciTech; 2020 Jan; 21(2):72. PubMed ID: 31953566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immediate release of poorly soluble drugs from starch-based pellets prepared via extrusion/spheronisation.
    Dukić-Ott A; Remon JP; Foreman P; Vervaet C
    Eur J Pharm Biopharm; 2007 Nov; 67(3):715-24. PubMed ID: 17537625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Formulation Development and evaluation of fast disintegrating tablets of Lamotrigine using liqui-solid technique.
    Koteswari P; Sunium S; Srinivasababu P; Babu GK; Nithya PD
    Int J Pharm Investig; 2014 Oct; 4(4):207-14. PubMed ID: 25426442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immediate release pellets with lipid binders obtained by solvent-free cold extrusion.
    Krause J; Thommes M; Breitkreutz J
    Eur J Pharm Biopharm; 2009 Jan; 71(1):138-44. PubMed ID: 18805483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancement of dissolution rate of class II drugs (Hydrochlorothiazide); a comparative study of the two novel approaches; solid dispersion and liqui-solid techniques.
    Khan A; Iqbal Z; Shah Y; Ahmad L; Ismail ; Ullah Z; Ullah A
    Saudi Pharm J; 2015 Nov; 23(6):650-7. PubMed ID: 26702260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of chitosan and sodium alginate and formulation variables on the formation and drug release from pellets prepared by extrusion/spheronisation.
    Chatchawalsaisin J; Podczeck F; Newton JM
    Int J Pharm; 2004 May; 275(1-2):41-60. PubMed ID: 15081137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of starch-based pellets via extrusion/spheronisation.
    Dukić A; Mens R; Adriaensens P; Foreman P; Gelan J; Remon JP; Vervaet C
    Eur J Pharm Biopharm; 2007 Apr; 66(1):83-94. PubMed ID: 17045467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influence of the extrusion die on pellet characteristics.
    Rabisková M; Weingartová D; Häring A
    Ceska Slov Farm; 2007 Jan; 56(1):17-20. PubMed ID: 17432277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coatless alginate pellets as sustained-release drug carrier for inflammatory bowel disease treatment.
    Md Ramli SH; Wong TW; Naharudin I; Bose A
    Carbohydr Polym; 2016 Nov; 152():370-381. PubMed ID: 27516284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Solid self-microemulsifying drug delivery system of ritonavir.
    Deshmukh A; Kulkarni S
    Drug Dev Ind Pharm; 2014 Apr; 40(4):477-87. PubMed ID: 23465049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of multiple-unit pellet system tablets by employing the SeDeM expert diagram system II: pellets containing different active pharmaceutical ingredients.
    Hamman H; Hamman J; Wessels A; Scholtz J; Steenekamp J
    Pharm Dev Technol; 2019 Feb; 24(2):145-156. PubMed ID: 29394129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.